- Report
- February 2025
- 150 Pages
Global
From €5230EUR$5,950USD£4,524GBP
- Report
- April 2025
- 175 Pages
Global
From €3947EUR$4,490USD£3,414GBP
- Report
- February 2025
- 185 Pages
Global
From €3955EUR$4,500USD£3,421GBP
- Report
- April 2023
- 110 Pages
Global
From €4175EUR$4,750USD£3,611GBP
- Report
- August 2023
- 120 Pages
Global
From €3955EUR$4,500USD£3,421GBP
- Report
- July 2022
- 99 Pages
Europe
From €1318EUR$1,500USD£1,140GBP
The Veterinary Biomarkers market is a segment of the Animal Healthcare/Veterinary industry that focuses on the development and use of biomarkers to diagnose, monitor, and treat diseases in animals. Biomarkers are biological molecules that can be used to measure the presence or absence of a disease, or to monitor the progression of a disease. Veterinary biomarkers are used to diagnose and monitor a wide range of diseases in animals, including cancer, infectious diseases, and metabolic disorders. Veterinary biomarkers can also be used to monitor the effectiveness of treatments and to predict the risk of disease in animals.
Companies in the Veterinary Biomarkers market include Abaxis, IDEXX Laboratories, Neogen Corporation, and Zoetis. Show Less Read more